Cytovene, Ganzyk-rtu, Vitrasert, Zirgan (ganciclovir) is a small molecule pharmaceutical. Ganciclovir was first approved as Cytovene on 1994-12-22. It is used to treat aids-related opportunistic infections, cytomegalovirus infections, and cytomegalovirus retinitis in the USA. Cytovene iv's patent is valid until 2034-09-02 (FDA).
|Trade Name||Cytovene, Ganzyk-rtu, Vitrasert, Zirgan|
|Indication||aids-related opportunistic infections, cytomegalovirus infections, cytomegalovirus retinitis|
|Drug Class||Antivirals: antivirals (acyclovir type)|